Environmental Assessments and Findings of No Significant Impact

Özet

The Food and Drug Administration (FDA) is announcing that it has reviewed environmental assessments (EA's) and issued findings of no significant impact (FONSI's) relating to the 141 new drug applications (NDA's), abbreviated new drug applications (ANDA's), and supplemental applications listed in this document. FDA is publishing this notice because Federal regulations require public notice of the availability of environmental documents.